Zobrazeno 1 - 1
of 1
pro vyhledávání: '"G. H. deBock"'
Autor:
I. M. Horstman, P. C. Vinke, E. Suazo‐Zepeda, T. J. N. Hiltermann, M. A. Heuvelmans, E. Corpeleijn, G. H. deBock
Publikováno v:
Thoracic Cancer, Vol 15, Iss 23, Pp 1764-1771 (2024)
Abstract Objectives Pretreatment biomarkers are needed to identify patients with non‐small‐cell lung cancer (NSCLC) likely to have worse survival. This ensures that only patients with a real chance of benefit receive immune checkpoint inhibitor (
Externí odkaz:
https://doaj.org/article/dbf5d2f74ba34f8f8e2c2581396efe26
